Drugs / Jinfeng Pill
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07606755 | May 2026 → May 2028 expected | — | Tongji Hospital | Recruiting | No outcome recorded |
| Phase 4 | NCT06823830 | Sep 2023 → Feb 2025 overdue | polycystic ovary syndrome | Peking Union Medical College Hospital | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Jinfeng Pill | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07606755 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Jinfeng Pill is a traditional Chinese medicine patented drug that has been widely used in gynecological disorders.” NCT07606755 ↗ |